Overview

BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation

Status:
Recruiting
Trial end date:
2023-11-30
Target enrollment:
Participant gender:
Summary
The main goal is to investigate whether beta cell mass is correlated to beta cell function after autologous faecal microbial transplantation (FMT) in patients with newly diagnosed type 1 diabetes
Phase:
Phase 2
Details
Lead Sponsor:
Radboud University Medical Center
Treatments:
Exenatide